Life Science Investing AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
life science investing Exclusive UK Packaging Agreement signed between Sharpak Aylesham Limited, Zoono, and OSY
Life Science Investing Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
Life Science Investing U.S. FDA Approves EMRELIS for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer With High c-Met Protein Overexpression
Life Science Investing AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
Life Science Investing Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
Life Science Investing BOTOX® Cosmetic Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
Life Science Investing Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy 28th Annual Meeting
Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing